A clinical trial to study the effects of two different modification of instrument (Laryngoscope) used for intubation in patients undergoing surgery under general anaesthesia.

Comparison of the recovery profile of 50 mcg dexmeditomidine as an adjuvant in 0.75% Ropivacaine in Transverse abdominis plane block and rectus sheath block vs 50 mcg intravenous Dexmeditomidine in patients undergoing Laparoscopic Cholecystectomy under general anaesthesia: A prospective randomized controlled double blinded study

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032752

Enrollment

Registered

2021-04-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexdemetomidine IV group: 50 microgram Dexemdetomidine is infused over 20 minutes after intubation to patients in this group Control Intervention1: Dexmedetomidine Block group: 50 micro

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 MPC 1 and 2 Patients undergoing ENT and General surgery under general anaesthesia

Exclusion criteria

Exclusion criteria: ASA 2,3,4,5 MPC 3 and 4 Emergency procedures Difficult intubation Nasal tracheal intubation Patients refusal

Design outcomes

Primary

Measure	Time frame
1. TIME TO OPEN EYES AFTER STOPPING INHALATION AGENT 2. TIME TO EXTUBATE AFTER STOPPING INHALATION AGENT Timepoint: T0 - STOPPING INHALATION AGENT T1- T7 - EVERY 15 MINUTES FROM STOPPING INHALATION AGENT.	—

Secondary

Measure	Time frame
Haemodynamics variablesTimepoint: Time to reach base line Pulse Rate	—

Countries

India

Contacts

Public ContactDr B Gayathri

SRM Medical College and Research Centre

gayathrii.r@gmail.com9500092905

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026